Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review

被引：21

作者：

Prieto-Pena, Diana ^{[4
]}

Bernabeu, Pilar ^{[5
]}

Vela, Paloma ^{[5
]}

Narvaez, Javier ^{[6
]}

Fernandez-Lopez, Jesus C. ^{[7
]}

Freire-Gonzalez, Mercedes ^{[7
]}

Gonzalez-Alvarez, Beatriz ^{[8
]}

Solans-Laque, Roser ^{[9
]}

Callejas Rubio, Jose L. ^{[10
]}

Ortego, Norberto ^{[10
]}

Fernandez-Diaz, Carlos ^{[11
]}

Rubio, Esteban ^{[12
]}

Garcia-Morillo, Salvador ^{[12
]}

Minguez, Mauricio ^{[13
]}

Fernandez-Carballido, Cristina ^{[13
]}

de Miguel, Eugenio ^{[14
]}

Melchor, Sheila ^{[15
]}

Salgado, Eva ^{[16
]}

Bravo, Beatriz ^{[17
]}

Romero-Yuste, Susana ^{[18
]}

Salvatierra, Juan ^{[10
]}

Hidalgo, Cristina ^{[19
]}

Manrique, Sara ^{[20
]}

Romero-Gomez, Carlos ^{[20
]}

Moya, Patricia ^{[21
]}

Alvarez-Rivas, Noelia ^{[22
]}

Mendizabal, Javier ^{[23
]}

Ortiz-Sanjuan, Francisco ^{[24
]}

Perez de Pedro, Ivan ^{[25
]}

Alonso-Valdivielso, Jose L. ^{[26
]}

Perez-Sanchez, Laura ^{[27
]}

Roldan, Rosa ^{[27
]}

Fernandez-Llanio, Nagore ^{[28
]}

Gomez de la Torre, Ricardo ^{[29
]}

Suarez, Silvia ^{[29
]}

Montesa Cabrera, Maria Jesus ^{[8
]}

Delgado Sanchez, Monica ^{[8
]}

Loricera, Javier ^{[4
]}

Atienza-Mateo, Belen ^{[4
]}

Castaneda, Santos ^{[11
,30
]}

Gonzalez-Gay, Miguel A. ^{[1
,2
,3
]}

Blanco, Ricardo ^{[4
]}

机构：

[1] Hosp Univ Marques de Valdecilla, Rheumatol Div, Res Grp Genet Epidemiol & Atherosclerosis Syst Di, IDIVAL, Ave Valdecilla S-N, Santander 39008, Spain

[2] Univ Cantabria, Sch Med, Santander, Spain

[3] Univ Witwatersrand, Fac Hlth Sci, Sch Physiol, Cardiovasc Pathophysiol & Genom Res Unit, Johannesburg, South Africa

[4] Hosp Univ Marques de Valdecilla, Dept Rheumatol, IDIVAL, Res Grp Genet Epidemiol & Atherosclerosis Syst Di, Santander, Spain

[5] Hosp Gen Alicante, Dept Rheumatol, Alicante, Spain

[6] Hosp Bellvitge Princeps Espanya, Dept Rheumatol, Barcelona, Spain

[7] Complejo Hosp Univ A Coruna, Dept Rheumatol, La Coruna, Spain

[8] Hosp Nuestra Senora Candelaria, Dept Rheumatol, Tenerife, Spain

[9] Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain

[10] Hosp San Cecilio, Autoimmune Dis Unit, Granada, Spain

[11] Hosp Univ Princesa, Dept Rheumatol, IIS Princesa, Madrid, Spain

[12] Hosp Virgen Rocio, Autoimmune Dis Unit, Seville, Spain

[13] Hosp San Juan Alicante, Dept Rheumatol, Alicante, Spain

[14] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain

[15] Hosp Univ 12 Octubre, Dept Rheumatol, Madrid, Spain

[16] Complejo Hosp Univ Ourense, Dept Rheumatol, Orense, Spain

[17] Hosp Virgen Nieves, Dept Rheumatol, Granada, Spain

[18] Complejo Hosp Univ Pontevedra, Dept Rheumatol, Pontevedra, Spain

[19] Complejo Univ Salamanca, Dept Rheumatol, Salamanca, Spain

[20] Hosp Reg Malaga, Autoimmune Dis Unit, Malaga, Spain

[21] Hosp Santa Creu & Sant Pau, Dept Rheumatol, Barcelona, Spain

[22] Hosp Univ San Agustin, Dept Rheumatol, Aviles, Spain

[23] Complejo Hosp Navarra, Dept Rheumatol, Pamplona, Spain

[24] Hosp Univ & Politecn La Fe, Dept Rheumatol, Valencia, Spain

[25] Hosp Carlos Haya, Autoimmune Dis Unit, Malaga, Spain

[26] Hosp Univ Burgos, Dept Rheumatol, Burgos, Spain

[27] Hosp Univ Reina Sofia, Dept Rheumatol, Cordoba, Spain

[28] Hosp Arnau Vilanova, Dept Rheumatol, Valencia, Spain

[29] Hosp Univ Cent Asturias, Autoimmune Dis Unit, Oviedo, Spain

[30] Univ Autonoma Madrid IUAMI, UAM ROCHE, EPID Future, Madrid, Spain

来源：

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE | 2021年 / 13卷

关键词：

biological therapy; Caucasian; cDMARDs; Takayasu's arteritis; Tocilizumab; DISEASE-ACTIVITY; EPIDEMIOLOGY; EFFICACY; FEATURES; CRITERIA; OUTCOMES; SAFETY; JAPAN;

D O I：

10.1177/1759720X211020917

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with refractory Takayasu's arteritis (TAK) in clinical practice. Methods: A multicenter study of Caucasian patients with refractory TAK who received TCZ. The outcome variables were remission, glucocorticoid-sparing effect, improvement in imaging techniques, and adverse events. A comparative study between patients who received TCZ as monotherapy (TCZ(MONO)) and combined with conventional disease modifying anti-rheumatic drugs (cDMARDs) (TCZ(COMBO)) was performed. Results: The study comprised 54 patients (46 women/8 men) with a median [interquartile range (IQR)] age of 42.0 (32.5-50.5) years. TCZ was started after a median (IQR) of 12.0 (3.0-31.5) months since TAK diagnosis. Remission was achieved in 12/54 (22.2%), 19/49 (38.8%), 23/44 (52.3%), and 27/36 (75%) patients at 1, 3, 6, and 12 months, respectively. The prednisone dose was reduced from 30.0 mg/day (12.5-50.0) to 5.0 (0.0-5.6) mg/day at 12 months. An improvement in imaging findings was reported in 28 (73.7%) patients after a median (IQR) of 9.0 (6.0-14.0) months. Twenty-three (42.6%) patients were on TCZ(MONO) and 31 (57.4%) on TCZ(COMBO): MTX (n = 28), cyclosporine A (n = 2), azathioprine (n = 1). Patients on TCZ(COMBO) were younger [38.0 (27.0-46.0) versus 45.0 (38.0-57.0)] years; difference (diff) [95% confidence interval (CI) = -7.0 (-17.9, -0.56] with a trend to longer TAK duration [21.0 (6.0-38.0) versus 6.0 (1.0-23.0)] months; diff 95% CI = 15 (-8.9, 35.5), and higher c-reactive protein [2.4 (0.7-5.6) versus 1.3 (0.3-3.3)] mg/dl; diff 95% CI = 1.1 (-0.26, 2.99). Despite these differences, similar outcomes were observed in both groups (log rank p = 0.862). Relevant adverse events were reported in six (11.1%) patients, but only three developed severe events that required TCZ withdrawal. Conclusion: TCZ in monotherapy, or combined with cDMARDs, is effective and safe in patients with refractory TAK of Caucasian origin.

引用

页数：12

共 30 条

[1] Efficacy and Safety of Anti-Interleukin 6 Receptor Monoclonal Antibody (Tocilizumab) in Colombian Patients With Takayasu Arteritis [J].

Alberto Canas, Carlos ;

Canas, Felipe ;

Hernan Izquierdo, Jorge ;

Echeverri, Andres-Felipe ;

Mejia, Mauricio ;

Bonilla-Abadia, Fabio ;

Tobon, Gabriel J. .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (03) :125-129

[2]

AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129

[3] Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise [J].

Aydin, Sibel Z. ;

Direskeneli, Haner ;

Merkel, Peter A. .

JOURNAL OF RHEUMATOLOGY, 2017, 44 (12) :1928-1932

[4] Imaging modalities for the diagnosis and disease activity assessment of Takayasu's arteritis: A systematic review and meta-analysis [J].

Barra, Lillian ;

Kanji, Tahir ;

Malette, Jacqueline ;

Pagnoux, Christian .

AUTOIMMUNITY REVIEWS, 2018, 17 (02) :175-187

[5] Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice [J].

Calderon-Goercke, Monica ;

Loricera, Javier ;

Aldasoro, Vicente ;

Castaneda, Santos ;

Villa, Ignacio ;

Humbria, Alicia ;

Moriano, Clara ;

Romero-Yuste, Susana ;

Narvaez, Javier ;

Gomez-Arango, Catalina ;

Perez-Pampin, Eva ;

Melero, Rafael ;

Becerra-Fernandez, Elena ;

Revenga, Marcelino ;

Alvarez-Rivas, Noelia ;

Galisteo, Caries ;

Sivera, Francisca ;

Olive-Marques, Alejandro ;

Alvarez del Buergo, Maria ;

Marena-Rojas, Luisa ;

Fernandez-Lopez, Carlos ;

Navarro, Francisco ;

Raya, Enrique ;

Galindez-Agirregoikoa, Eva ;

Arca, Beatriz ;

Solans-Laque, Roser ;

Conesa, Arantxa ;

Hidalgo, Cristina ;

Vazquez, Carlos ;

Andres Roman-Ivorra, Jose ;

Lluch, Pau ;

Manrique-Arija, Sara ;

Vela, Paloma ;

De Miguel, Eugenio ;

Torres-Martin, Carmen ;

Carlos Nieto, Juan ;

Ordas-Calvo, Carmen ;

Salgado-Perez, Eva ;

Luna-Gomez, Cristina ;

Toyos-Saenz de Miera, F. Javier ;

Fernandez-Llanio, Nagore ;

Garcia, Antonio ;

Larena, Carmen ;

Palmou-Fontana, Natalia ;

Calvo-Rio, Vanesa ;

Prieto-Pena, Diana ;

Gonzalez-Vela, Carmen ;

Corrales, Alfonso ;

Varela-Garcia, Maria ;

Aurrecoechea, Elena .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (01) :126-135

[6] Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis A Multicenter Study of 318 Patients [J].

Comarmond, Cloe ;

Biard, Lucie ;

Lambert, Marc ;

Mekinian, Arsene ;

Ferfar, Yasmina ;

Kahn, Jean-Emmanuel ;

Benhamou, Ygal ;

Chiche, Laurent ;

Koskas, Fabien ;

Cluzel, Philippe ;

Hachulla, Eric ;

Messas, Emmanuel ;

Resche-Rigon, Matthieu ;

Cacoub, Patrice ;

Mirault, Tristan ;

Saadoun, David .

CIRCULATION, 2017, 136 (12) :1114-1122

[7] Tocilizumab and refractory Takayasu disease: Four case reports and systematic review [J].

Decker, Paul ;

Olivier, Pierre ;

Risse, Jessie ;

Zuily, Stephane ;

Wahl, Denis .

AUTOIMMUNITY REVIEWS, 2018, 17 (04) :353-360

[8] Angiographic findings of Takayasu arteritis: New classification [J].

Hata, A ;

Noda, M ;

Moriwaki, R ;

Numano, F .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 1996, 54 :S155-S163

[9] 2018 Update of the EULAR recommendations for the management of large vessel vasculitis [J].

Hellmich, Bernhard ;

Agueda, Ana ;

Monti, Sara ;

Buttgereit, Frank ;

de Boysson, Hubert ;

Brouwer, Elisabeth ;

Cassie, Rebecca ;

Cid, Maria C. ;

Dasgupta, Bhaskar ;

Dejaco, Christian ;

Hatemi, Gulen ;

Hollinger, Nicole ;

Mahr, Alfred ;

Mollan, Susan P. ;

Mukhtyar, Chetan ;

Ponte, Cristina ;

Salvarani, Carlo ;

Sivakumar, Rajappa ;

Tian, Xinping ;

Tomasson, Gunnar ;

Turesson, Carl ;

Schmidt, Wolfgang ;

Villiger, Peter M. ;

Watts, Richard ;

Young, Chris ;

Luqmani, Raashid Ahmed .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (01) :19-30

[10] 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides [J].

Jennette, J. C. ;

Falk, R. J. ;

Bacon, P. A. ;

Basu, N. ;

Cid, M. C. ;

Ferrario, F. ;

Flores-Suarez, L. F. ;

Gross, W. L. ;

Guillevin, L. ;

Hagen, E. C. ;

Hoffman, G. S. ;

Jayne, D. R. ;

Kallenberg, C. G. M. ;

Lamprecht, P. ;

Langford, C. A. ;

Luqmani, R. A. ;

Mahr, A. D. ;

Matteson, E. L. ;

Merkel, P. A. ;

Ozen, S. ;

Pusey, C. D. ;

Rasmussen, N. ;

Rees, A. J. ;

Scott, D. G. I. ;

Specks, U. ;

Stone, J. H. ;

Takahashi, K. ;

Watts, R. A. .

ARTHRITIS AND RHEUMATISM, 2013, 65 (01) :1-11

← 1 2 3 →